PCN4 COST-UTILITY ANALYSIS OF FULVESTRANT VERSUS EXEMESTANE IN THE SECOND LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER

Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65738-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)65738-5/fulltext
Title : PCN4 COST-UTILITY ANALYSIS OF FULVESTRANT VERSUS EXEMESTANE IN THE SECOND LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65738-5&doi=10.1016/S1098-3015(10)65738-5
First page :
Section Title :
Open access? : No
Section Order : 104
Categories :
Tags :
Regions :
ViH Article Tags :